OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial

Background: Pediatric obesity is a chronic disease with rising prevalence and limited treatment options; first-line intervention is lifestyle therapy, which is typically unsuccessful.(1) Liraglutide (3.0 mg) as an adjunct to lifestyle therapy has provided weight loss and improved cardiometabolic ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Aaron S, Auerbach, Pernille, Barrientos-Perez, Margarita, Gies, Inge, Hale, Paula M, Marcus, Claude, Mastrandrea, Lucy D, Prabhu, Nandana, Arslanian, Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208432/
http://dx.doi.org/10.1210/jendso/bvaa046.413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208432/
http://dx.doi.org/10.1210/jendso/bvaa046.413

Ejemplares similares